Wnt/ß-catenin: a new therapeutic approach to acute myeloid leukemia.
about
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?β-catenin induces expression of prohibitin gene in acute leukemic cellsTargeting acute myeloid leukemia stem cell signaling by natural products.Targeting self-renewal pathways in myeloid malignancies.Disruption of Wnt/β-catenin exerts anti-leukemia activity and synergizes with FLT3 inhibition in FLT3-mutant acute myeloid leukemia.
P2860
Wnt/ß-catenin: a new therapeutic approach to acute myeloid leukemia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Wnt/ß-catenin: a new therapeutic approach to acute myeloid leukemia.
@en
Wnt/ß-catenin: a new therapeutic approach to acute myeloid leukemia.
@nl
type
label
Wnt/ß-catenin: a new therapeutic approach to acute myeloid leukemia.
@en
Wnt/ß-catenin: a new therapeutic approach to acute myeloid leukemia.
@nl
prefLabel
Wnt/ß-catenin: a new therapeutic approach to acute myeloid leukemia.
@en
Wnt/ß-catenin: a new therapeutic approach to acute myeloid leukemia.
@nl
P2093
P2860
P356
P1476
Wnt/ß-catenin: a new therapeutic approach to acute myeloid leukemia.
@en
P2093
I G H Schmidt-Wolf
S Thanendrarajan
P2860
P304
P356
10.4061/2011/428960
P577
2011-12-01T00:00:00Z